Phosphogliv (Phospholipid, Glycyrrhizic acid) lyophilisate for solution preparation

Phosphogliv (Phospholipid, Glycyrrhizic acid) lyophilisate for solution preparation

To favorites
Combined agent Phosphogliv, has a membrane-stabilizing, hepatoprotective and antiviral effect
Active substance:Phospholipid, Glycyrrhizic acid
Pharmacological group:Hepatoprotectors
Dosage mg:2.5
In stock
We deliver goods to almost any country. Each parcel is assigned a track number
You can pay by Paypal or any card Visa or Mastercard
Discount system
Cumulative discounts and Bonus program for our clients
Original goods
We offer our customers only original products

Instructions for Phosphogliv (Phospholipid, Glycyrrhizic acid) lyophilisate for solution preparation

English product name

Dosage form
lyophilisate for cooking. solution d/v/v administration: fl. 2.5g five pieces included. with solvent


Lyophilisate for the preparation of a solution for intravenous administration in the form of a mass from white to light yellow color.

1 fl.
phospholipids (lipoid C100) 500 mg
sodium glycyrrhizinate (trisodium salt of glycyrrhizic acid) 200 mg
2.5 g - glass bottles (5) complete with solvent water d /i (amp. 10 ml 5 pcs.) - contour plastic packaging (1) - cardboard packs.

ATX Codes 
Preparations for the treatment of liver diseases A05BA

Clinical and pharmacological groups / Group affiliation
Hepatoprotector with immunomodulatory and antiviral action

Active ingredient
sodium glycyrrhizinate


Pharmaco-therapeutic group Phosphogliv
Hepatoprotective agent

Storage conditions
The drug should be stored out of the reach of children, protected from light at a temperature not exceeding 20 ° C. The period is two years.

Testimony Phosphogliv:

  • viral hepatitis (acute and chronic);
  • fatty degeneration of the liver (hepatosis);
  • other liver damage (medicinal, alcoholic, toxic);
  • cirrhosis of the liver;
  • intoxication;
  • psoriasis;
  • neurodermatitis;
  • eczema.

Dosage, Course and Dosage Phosphogliv:

Adults and children over twelve years of age: intravenously, having previously dissolved the powder in 10 ml of water for injection. Intravenous administration should be carried out slowly. Inject 10 ml daily 2 times / day in the morning and evening for 10 days, followed by a transition to oral administration of the drug in the form of capsules. The duration of the course can be increased on the recommendation of a doctor.

Use in children
Contraindication: children under 12 years of age.

  • Nosology (ICD codes)
  • B15
  • Acute hepatitis A
  • B16
  • Acute hepatitis B
  • B17.1
  • Acute hepatitis C
  • B18.1
  • Chronic viral hepatitis B without delta agent
  • B18.2
  • Chronic viral hepatitis C
  • K70
  • Alcoholic liver disease
  • K71
  • Toxic liver damage
  • K73
  • Chronic hepatitis not classified under other headings
  • K74
  • Fibrosis and cirrhosis of the liver
  • L20.8
  • Other atopic dermatitis (neurodermatitis, eczema)
  • L40
  • Psoriasis

pharmachologic effect:

Combined drug Phosphogliv.

It has a membrane-stabilizing, hepatoprotective and antiviral effect.
Phosphatidylcholine (the main component of phospholipids) is the main structural element of cellular and intracellular membranes, is able to restore their structure and functions when damaged, providing a cytoprotective effect. Normalizes protein and lipid metabolism, prevents the loss of enzymes and other active substances by hepatocytes, restores the detoxifying function of the liver, inhibits the formation of connective tissue, reducing the risk of liver fibrosis and cirrhosis.

Active substance
Pharmacological group
Dosage mg
Pills in 1 package
Country of origin
Expiration Date (in months)
No reviews yet — your comment may be first.
All reviews 0
general rating